| Serial Number | 79352105 |
| Word Mark | ULTIMÉ |
| Filing Date | Tuesday, July 19, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, January 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Antioxidants (dietary supplements); antibiotic food supplements for animals; nutritional supplements; vitamin supplements; vitamin supplements for animals; capsules for pharmaceutical purposes; eucalyptus for pharmaceutical purposes; flaxseed for pharmaceutical purposes; gallic acid for pharmaceutical purposes; lactose for pharmaceutical purposes; meal for pharmaceutical purposes; moisturising body lotion (pharmaceutical); moisturising creams (pharmaceutical); moisturising gels (pharmaceutical); moisturising lotions (pharmaceutical); moisturising skin creams (pharmaceutical); moisturising skin lotions (pharmaceutical); oils for pharmaceutical purposes; pain killers (pharmaceuticals); pharmaceutical compound eye-drops; pharmaceutical anticoagulant preparations; pharmaceutical appetite suppressants; pharmaceutical compositions; pharmaceutical creams; pharmaceutical cytostatic preparations; pharmaceutical cytostatic preparations for use in parenteral form; pharmaceutical drugs; pharmaceutical drugs being a positive inotropic agent; pharmaceutical lipsalves; pharmaceutical medicaments in unit dosage form; pharmaceutical preparations; pharmaceutical preparations being antacids; pharmaceutical preparations being antiulceratives; pharmaceutical preparations being hormone preparations for human use; pharmaceutical preparations containing a vasodilator; pharmaceutical preparations containing amino acids; pharmaceutical preparations containing calcitonin; pharmaceutical preparations containing coagulants; pharmaceutical preparations containing enzymes; pharmaceutical preparations containing essential oils; pharmaceutical preparations containing fish oil; pharmaceutical preparations containing fluoride for prevention of dental decay; pharmaceutical preparations containing hormones for humans; pharmaceutical preparations containing royal jelly; pharmaceutical preparations containing vitamins; pharmaceutical preparations for alleviating disorders of the brain; pharmaceutical preparations for animals; pharmaceutical preparations for application to the skin; pharmaceutical preparations for assisting the prevention of bone diseases; pharmaceutical preparations for enteral administration; pharmaceutical preparations for growing eyebrows; pharmaceutical preparations for growing eyelashes; pharmaceutical preparations for health care; pharmaceutical preparations for human use; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for personal use; pharmaceutical preparations for promoting the maturation of the cervix; pharmaceutical preparations for skin care; pharmaceutical preparations for the preservation and storage of human organs; pharmaceutical preparations for the prevention of bone conditions; pharmaceutical preparations for the prevention of cardiovascular disorders; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of insect stings; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for the treatment of alcoholism; pharmaceutical preparations for the treatment of blackheads; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for the treatment of depressive illness; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of digestive maladies; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of dyslexia; pharmaceutical preparations for the treatment of gastric diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of gynaecological disorders; pharmaceutical preparations for the treatment of joint related diseases; pharmaceutical preparations for the treatment of pimples; pharmaceutical preparations for the treatment of premenstrual tension; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of psoriasis in human beings; pharmaceutical preparations for the treatment of spots; pharmaceutical preparations for the treatment of the eyes; pharmaceutical preparations for topical use; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for use as laxative; pharmaceutical preparations for use in dentistry; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gynaecology; pharmaceutical preparations for use in hypercholesterolemia therapy; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for use in the treatment of arthrosis; pharmaceutical preparations for use in the treatment of colostomy patients; pharmaceutical preparations for use in the treatment of diseases of the vertebral column; pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations for use in the treatment of ileostomy patients; pharmaceutical preparations for use in the treatment of lumbago; pharmaceutical preparations for use in the treatment of muscle tension; pharmaceutical preparations for use in the treatment of pimples; pharmaceutical preparations for use in the treatment of rheumatism; pharmaceutical tablets; pharmaceutical sweets; pharmaceutical substances; plant extracts for pharmaceutical purposes; plant extracts for pharmaceutical use; pharmaceutical tonic preparations; propolis for pharmaceutical purposes; skincare preparations (pharmaceutical); sprays for use on the body (pharmaceuticals); yeast extracts for pharmaceutical purposes; yeast for pharmaceutical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 14, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AUSTRALIA BIOTECHNOLOGY GROUP PTY LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Event Date | Event Description |
| Monday, April 1, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, March 13, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, March 13, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, January 3, 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, January 3, 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, January 3, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, July 10, 2023 | REFUSAL PROCESSED BY IB |
| Friday, June 16, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, June 16, 2023 | REFUSAL PROCESSED BY MPU |
| Tuesday, May 9, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, May 8, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, May 4, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, October 18, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, October 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 13, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |